These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 37092904)
1. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers. Lee MS; Kaseb AO; Pant S Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904 [TBL] [Abstract][Full Text] [Related]
2. Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis. Chidharla A; Rapoport E; Agarwal K; Madala S; Linares B; Sun W; Chakrabarti S; Kasi A Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373376 [TBL] [Abstract][Full Text] [Related]
3. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer. Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783 [TBL] [Abstract][Full Text] [Related]
5. Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients. Koldby KM; Mortensen MB; Detlefsen S; Pfeiffer P; Thomassen M; Kruse TA J Gastroenterol; 2019 Feb; 54(2):108-121. PubMed ID: 30242476 [TBL] [Abstract][Full Text] [Related]
6. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer. Shields MD; Chen K; Dutcher G; Patel I; Pellini B Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272 [TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer. Arisi MF; Dotan E; Fernandez SV Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457259 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection. Lonardi S; Nimeiri H; Xu C; Zollinger DR; Madison RW; Fine AD; Gjoerup O; Rasola C; Angerilli V; Sharma S; Wu HT; Palsuledesai CC; Malhotra M; Aleshin A; Loupakis F; Renkonen E; Hegde P; Fassan M Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232827 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal monitoring of KRAS-mutated circulating tumor DNA enables the prediction of prognosis and therapeutic responses in patients with pancreatic cancer. Watanabe F; Suzuki K; Tamaki S; Abe I; Endo Y; Takayama Y; Ishikawa H; Kakizawa N; Saito M; Futsuhara K; Noda H; Konishi F; Rikiyama T PLoS One; 2019; 14(12):e0227366. PubMed ID: 31891652 [TBL] [Abstract][Full Text] [Related]
10. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices. Malla M; Loree JM; Kasi PM; Parikh AR J Clin Oncol; 2022 Aug; 40(24):2846-2857. PubMed ID: 35839443 [TBL] [Abstract][Full Text] [Related]
11. A Review of Circulating Tumor DNA in the Diagnosis and Monitoring of Esophageal Cancer. Min J; Zhou H; Jiang S; Yu H Med Sci Monit; 2022 Feb; 28():e934106. PubMed ID: 35210388 [TBL] [Abstract][Full Text] [Related]
12. Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma. Ueberroth BE; Jones JC; Bekaii-Saab TS Pancreatology; 2022 Sep; 22(6):741-748. PubMed ID: 35725696 [TBL] [Abstract][Full Text] [Related]
13. Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis. Creemers A; Krausz S; Strijker M; van der Wel MJ; Soer EC; Reinten RJ; Besselink MG; Wilmink JW; van de Vijver MJ; van Noesel CJM; Verheij J; Meijer SL; Dijk F; Bijlsma MF; van Oijen MGH; van Laarhoven HWM Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):394-403. PubMed ID: 28801248 [TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma. Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281 [TBL] [Abstract][Full Text] [Related]
15. Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer. Wang S; Li M; Zhang J; Xing P; Wu M; Meng F; Jiang F; Wang J; Bao H; Huang J; Ren B; Yu M; Qiu N; Li H; Yuan F; Zhang Z; Jia H; Lu X; Zhang S; Wang X; Xu Y; Xia W; Liu T; Xu W; Xu X; Sun M; Wu X; Shao Y; Wang Q; Dai J; Qiu M; Wang J; Zhang Q; Xu L; Shen H; Yin R J Hematol Oncol; 2022 Oct; 15(1):137. PubMed ID: 36183093 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumour DNA as a biomarker in resectable and irresectable stage IV colorectal cancer; a systematic review and meta-analysis. Jones RP; Pugh SA; Graham J; Primrose JN; Barriuso J Eur J Cancer; 2021 Feb; 144():368-381. PubMed ID: 33422803 [TBL] [Abstract][Full Text] [Related]
17. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality. Salati M; Venetis K; Fassan M; Malapelle U; Pagni F; Sajjadi E; Fusco N; Ghidini M Future Oncol; 2021 Nov; 17(33):4607-4618. PubMed ID: 34406032 [TBL] [Abstract][Full Text] [Related]
18. Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases. Wang DS; Yang H; Liu XY; Chen ZG; Wang Y; Fong WP; Hu MT; Zheng YC; Zheng Y; Li BK; Yuan YF; Chen G; Pan ZZ; Song L; Li YH; Xu RH Theranostics; 2021; 11(14):7018-7028. PubMed ID: 34093868 [No Abstract] [Full Text] [Related]
19. Development of circulating tumour DNA analysis for gastrointestinal cancers. Nakamura Y; Shitara K ESMO Open; 2020 Jan; 5(Suppl 1):e000600. PubMed ID: 32830648 [TBL] [Abstract][Full Text] [Related]
20. Mind the target: circulating tumour DNA in gastrointestinal malignancies. Fontana E; Ignatova E Curr Opin Oncol; 2022 Jul; 34(4):395-402. PubMed ID: 35837709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]